Low- vs Standard Pressure Inflation of Oversized Drug-Coated Balloon for CAD Treatment
The use of oversized drug-coated balloons at low pressure was found to be effective in preventing late restenosis in patients with coronary artery disease.
The use of oversized drug-coated balloons at low pressure was found to be effective in preventing late restenosis in patients with coronary artery disease.
Adults with congenital heart defects are more likely to report cardiovascular comorbidities than those in the general population.
Systematic coronary artery calcium scoring screening and treatment of individuals with a family history of premature coronary artery disease and subclinical disease was found to be more cost-effective than management based on statin treatment thresholds.
A genetic risk score was found to be useful in identifying young individuals at high risk for coronary heart disease who need to undergo coronary artery calcium screening.
Women younger than 55 years with type 2 diabetes have a 10-fold greater risk for having coronary heart disease.
Female sex is associated with lower odds of undergoing guideline-concordant revascularization.
Percutaneous coronary intervention with paclitaxel-eluting balloons safe and effective for in-stent restenosis and de novo coronary lesions.
Greater levels of ADAMTS-9 were found to be associated with greater risk for MACE in patients with acute myocardial infarction.
Investigators aimed to determine whether the sickle cell trait was associated with myocardial infarction or coronary heart disease among African American individuals.
The C-reactive protein to albumin ratio is a novel inflammation marker that may be a valuable predictor of coronary artery lesion formation in Kawasaki disease.